BUY Aurobindo Pharma — Sharekhan Research, 11 Nov 2024

bySharekhan ResearchHorizon: NA (inferred 1 year)11 Nov 2024via Institutional / Brokerage Research

Entry₹1,289.05Inferred

Target₹1,532

Stop lossNot given

At expiry₹1,168.211 Nov 2025, 3:30 pm

Expired-9.38%

Follow Sharekhan Research for new calls(54% target hit, 510 closed calls)Get alerts Watch AUROPHARMA for new buy/sell callsGet alerts See 10 active Long-term calls on AUROPHARMA

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 11 Nov 2025

1 supporting0 opposing

Supports the BUY call (1)

6 other SEBI-registered advisors have active long-term BUY calls on this stock, with 4 issued in the last 14 days

Advisor consensus · same horizon·10 Nov · yesterday

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.